Gene therapy
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
Heart stents may offer alternative to chest pain medication for angina patients
Some patients with chest pain from reduced blood flow to the heart may benefit from having a stent implanted, instead of chest pain medications.
Number of extremely premature babies receiving neonatal care triples
The number of babies born at 22 weeks given respiratory life support in England and Wales increased three-fold after NHS guidelines changed in 2019.
AI stethoscope rolled out to 100 GP clinics to help diagnose heart failure
GP clinics in London and Wales will receive an AI-powered tool as part of a trial to help improve the diagnosis of a deadly heart condition.
Cumbria’s first medical school to launch in 2025 with £5m Pears Foundation gift
Imperial College London, the University of Cumbria and Pears Foundation will jointly launch The Pears Cumbria School of Medicine in 2025.
Mohn Centre secures collaborative funding for North West London
The Mohn Centre, with colleagues in North West London, has secured funding to investigate barriers of children participating in research.
Imperial takes lead on AI-driven innovation ahead of AI Safety Summit
Imperial College London has published a statement on AI-driven innovation to coincide with the UK AI Safety Summit, taking place on November 1 and 2.
New £28m Centre to forge the next generation of AI digital healthcare innovators
A new £28 million UKRI AI Centre for Doctoral Training at Imperial College London will train over 120 researchers to develop patient-ready technology.
1
Statin benefits patients with severe COVID-19 while vitamin C is ‘ineffective'
A common cholesterol-lowering drug may improve outcomes for critically ill patients with COVID-19, while high dose vitamin C is ineffective.
iCARE team’s innovation recognised at PENNA 2023
The Imperial Clinical Analytics, Research and Evaluation (iCARE) team won the Innovative Use of Technology, Social and Digital Media award.